European Archives - Page 697 of 1226 - European Medical Journal

Infographic: Brain–Computer Interfaces

A brain–computer interface (BCI) measures, analyses, and translates the activity of the central nervous system (CNS) into artificial…

Talking to Rob Jekielek

Rob Jekielek, Managing Director, The Harris Poll, discusses the evolving public perceptions of the pharma industry.

Chondroprotection: What, When, and Why?

Investigating osteoarthritis (OA), a long-term chronic disease that is increasing year on year due to population ageing and growth in related factors such as obesity.

EMJ 6.1 Feature Image

EMJ 6.1 2021

EMJ 6.1 brings together peer-reviewed research articles sharing topical advancements across a range of therapeutic disciplines, including cardiology, gastroenterology, microbiology, and more. These are accompanied by exciting features as well as interviews with world-class experts in dermatology and oncology, making this an issue that will cater to every clinician.

Emerging Treatments for Crohn's Disease cover image

Emerging Treatments for Crohn's Disease: Cells, Surgery, and Novel Therapeutics

Despite the development of multiple biological therapies for Crohn’s disease (CD), remission rates at 1 year from individual agents are still only 30–50%…

Pancreatic β-Cell Senescence feature image

Pancreatic β-Cell Senescence: Mechanisms and Association with Diabetes

Cellular senescence is a stress response to remove cell damage through immune system activation. The term ‘senescence’ was originally coined…

EMJ 6.1 Feature Image

Addressing the Unmet Need in Treatment of Nonmelanoma Skin Cancers: Interviews with Two Key Opinion Leaders

Nonmelanoma skin cancers (NMSC) are a diverse group of cutaneous malignancies and are the most common forms of human neoplasia worldwide…

EMJ 6.1 Feature Image

The Treatment Landscape of Atopic Dermatitis: Interviews with Three Consultant Dermatologists

Atopic dermatitis (AD), sometimes referred to as ‘atopic eczema’, is a common, chronic, pruritic, Type II inflammatory skin disease which is associated…

Is CD37-Targeted Therapy a Viable Alternative in the Treatment of Diffuse Large B-cell Lymphoma? Interviews with Two Key Opinion Leaders

Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma and the most frequent non-Hodgkin lymphoma (NHL) in adults, accounting for 30–40%…

Transient Cutaneous Alterations of the Newborn

At birth, the skin of the newborn suddenly comes into contact with the extrauterine world: a dry and aerobic environment.1 Newborn skin is 40–60%…